Treating opioid addiction may be harder than you think
OHSU study finds it's easy to get opioids but increasingly difficult to get medical assisted help when it comes to treating opioid addiction.
According to...
The New Modalities Ecosystem: a much-needed boost for rare diseases
The collaborative New Modalities Ecosystem unites academia, pharma and technology companies to drive real and meaningful progress in research and treatments for rare diseases.
IN...
Psoriasis medication may have the ability to improve heart disease
For patients with the skin condition, researchers found that psoriasis medication may have improved heart disease and coronary artery plaque.
Published today in Cardiovascular Research,...
Want to know the latest in vaccines for animal diseases?
The development of new and better vaccines holds enormous promise in efforts to tackle a range of animal diseases, from post-weaning diarrhoea to deadly...
Do you feel like you’re being overprescribed with antibiotics?
According to the National Health Service, researchers estimate that as much as 23% of recommended antibiotics could be inappropriately prescribed.
A new study in the...
Reducing use of medicines in agriculture
Gwyn Jones, chairman of RUMA, talks reducing unnecessary use of antimicrobials and medicines in agriculture and their dissemination into the environment.
Chairman of the Responsible...
Self-administer long-term contraception via microneedle patch
A new long-term contraception has been designed for women to self-administer using a microneedle patch.
Providing a new family planning option, particularly in developing nations...
Influenza vaccines launched by Seqirus
First ever cell-based quadrivalent influenza vaccines available in Europe and is licensed for use for people nine years and above.
Seqirus, a global leader in...
Enhancing analysis of clinical biomarkers in medicine
Published in Genomic Medicine, researchers present new genetic testing technology which enhances precision of analysis of clinical biomarkers in medicine.
A team of researchers from...
Blockchain in healthcare: medical cannabis prescription service
German start-up, MedPayRx, is piloting blockchain in healthcare, with a digital prescription service that bills products, such as medical cannabis, in the form of...
Clostridium difficile infection may be increased by painkillers
People treated with antibiotics are at heightened risk of having clostridium difficile infection as those drugs disturb the microbial balance of the gut.
Clostridium difficile...
The global alliance of Tilray and Novartis – revolutionising medicinal cannabis
An evolution of the existing alliance between Tilray and Novartis Group is set to increase availability of high-quality medicinal cannabis across the world.
Tilray Canada...
Universal meningitis vaccination is not cost-effective for all
According to Johns Hopkins Medicine, providing universal meningitis vaccination against infection may be too costly to justify cases it would prevent.
Meningitis vaccination is highly...
Motor neuron disease symptoms may be relieved by cannabis sativa plant
An oral spray containing two compounds derived from the cannabis sativa plant reduces spasticity in patients experiencing motor neuron disease symptoms.
Researchers from San Raffaele...
We need to focus more on antidepressant withdrawal relief
Researchers analyse data that can guide antidepressant discontinuation and enable an individual to experience some form of antidepressant withdrawal relief.
There has been a significant...
Inaccuracy in electronic prescribing is warned
Researchers caution warning when using electronic prescribing, as errors are likely to occur in medical record systems.
Electronic prescribing is becoming increasingly common across the...
Opioid-related social isolation could be solved by activating parts of the brain
Opioid-related social isolation is one of the most challenging aspects of the US opioid crisis, however researchers may have cracked the code to help...
EU drug packaging deadline may be missed in event of a no-deal Brexit
Many EU and US pharma companies are unaware that if a no-deal Brexit is reached, they will need to meet a crucial EU drug...
Can a biosynthetic pathway be a new route to antibiotic use?
Scientists have discovered a new route to antibiotic use, exploiting a chemical process and gene editing, also known as a biosynthetic pathway.
Researchers from The...
Concomitant use of benzodiazepine drugs common amongst AD patients
The most commonly concomitant use amongst AD patients was benzodiazepine drugs and a weak opioid – where one in five people with Alzheimer’s disease...